The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DSM-Firmenich AG
F:ZX6
|
CH |
|
Industrivarden AB
OTC:IDDTF
|
SE |
|
Technical Communications Corp
OTC:TCCO
|
US |
|
S
|
St James's Place PLC
F:1IV
|
UK |
|
S
|
SK Discovery Co Ltd
KRX:006125
|
KR |
|
V
|
Vistance Networks Inc
XMUN:CM9
|
US |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
M
|
My Humble House Hospitality Management Consulting Co Ltd
TWSE:2739
|
TW |
|
C
|
Cloudcoco Group PLC
F:GV2A
|
UK |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Fission 3.0 Corp
XTSX:FUU
|
CA |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
Moho Resources Ltd
ASX:MOH
|
AU |
|
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
|
US |
|
T
|
Trek 2000 International Ltd
SGX:5AB
|
SG |
|
S
|
Seabridge Gold Inc
NYSE:SA
|
CA |
|
O
|
Obic Co Ltd
F:OBL
|
JP |
|
Ebro Foods SA
F:AZU
|
ES |
|
G
|
Genix Pharmaceuticals Corp
OTC:GENPF
|
CA |
|
Kusuri No Aoki Holdings Co Ltd
TSE:3549
|
JP |
|
C
|
CaixaBank SA
SWB:48CA
|
ES |
|
A
|
ACS Actividades de Construccion y Servicios SA
DUS:OCI1
|
ES |
|
Amcor PLC
OTC:AMCCF
|
UK |
DSM-Firmenich AG (ZX6)’s 12-month stock price forecast through October 2027 has a consensus target of €100.01, implying 8% downside. The forecast is based on price targets from 27 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for ZX6 is 100.01 EUR with a low forecast of 75.18 EUR and a high forecast of 122.91 EUR.
Over the last 3 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 6%.
Over the last 3 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.
Over the last 3 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 26%.
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 27%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more